BRIEF published on 03/31/2026 at 15:32, 2 months 25 days ago The Vanguard Group Engages in Picton Property Income Limited Disclosure Takeover Code Vanguard Group Shareholding Picton Property
BRIEF published on 03/31/2026 at 15:32, 2 months 25 days ago Le groupe Vanguard s'engage dans Picton Property Income Limited Actionnariat Groupe Vanguard Code De Prise De Contrôle Divulgation Propriété Picton
BRIEF published on 03/31/2026 at 15:31, 2 months 25 days ago The Vanguard Group Discloses Position in NCC Group plc Takeover Code Securities Disclosure Vanguard Group Shareholdings NCC Group
BRIEF published on 03/31/2026 at 15:31, 2 months 25 days ago Le groupe Vanguard révèle sa participation dans NCC Group plc Participations Groupe Vanguard Code De Prise De Contrôle Information Sur Les Valeurs Mobilières Groupe NCC
PRESS RELEASE published on 03/31/2026 at 15:30, 2 months 25 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses 3.59% ownership in Spire Healthcare Group plc. Sale of 1p ordinary shares at 1.45 GBP per unit Vanguard Group Ownership Disclosure Spire Healthcare Sale 1p Ordinary Shares
BRIEF published on 03/31/2026 at 15:29, 2 months 26 days ago The Vanguard Group Discloses Stake in Just Group plc Securities Form 8.3 Takeover Code Vanguard Group Just Group Plc
BRIEF published on 03/31/2026 at 15:29, 2 months 26 days ago Le groupe Vanguard révèle sa participation dans Just Group plc Titres Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Just Group Plc
BRIEF published on 03/31/2026 at 15:28, 2 months 26 days ago Vanguard Group Discloses Significant Stake in JTC plc Securities Disclosure Vanguard Group Financial Markets Stakeholding JTC Plc
BRIEF published on 03/31/2026 at 15:28, 2 months 26 days ago Le groupe Vanguard révèle une participation significative dans JTC plc Marchés Financiers Groupe Vanguard Information Sur Les Valeurs Mobilières Parties Prenantes JTC Plc
PRESS RELEASE published on 03/31/2026 at 15:27, 2 months 26 days ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. discloses a 2.55% stake in Schroders plc as of 30 March 2026. Details in Form 8.3 under Rule 8.3 of the Takeover Code Form 8.3 Takeover Code Schroders Plc Vanguard Group Stake Disclosure
Published on 06/26/2026 at 14:05, 1 hour 25 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 1 hour 30 minutes ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 2 hours 30 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 12:45, 2 hours 45 minutes ago Northern Dynasty Reports Oral Arguments Held
Published on 06/26/2026 at 15:17, 12 minutes ago Form 8.3 - The Vanguard Group, Inc.: Intertek Group plc
Published on 06/26/2026 at 15:17, 12 minutes ago Form 8.3 - The Vanguard Group, Inc.: International Personal Finance plc
Published on 06/26/2026 at 15:16, 13 minutes ago Form 8.3 - The Vanguard Group, Inc.: Gamma Communications plc
Published on 06/26/2026 at 07:00, 8 hours 30 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 8 hours 30 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
